Holders — by stockHoldings — by fund
DAFNA Capital Management LLC
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-06-30 · filed with the SEC up to 45 days after quarter end · CIK 0001389933
$524.4M
disclosed book value
88
positions
20.1%
largest position share
Positions, as of 2026-06-30
top 88 of 88 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | RVMDREVOLUTION MEDICINES INC | 562,630 | $105.4M | 20.1% |
| 2 | XBISPDR S&P BIOTECH ETF | 196,505 | $31.1M | 5.9% |
| 3 | CMPSCOMPASS PATHWAYS PLC | 2.0M | $28.5M | 5.4% |
| 4 | STXSSTEREOTAXIS INC | 13.7M | $23.5M | 4.5% |
| 5 | NKTRNEKTAR THERAPEUTICS | 318,380 | $22.2M | 4.2% |
| 6 | DNLIDENALI THERAPEUTICS INC | 739,014 | $19.0M | 3.6% |
| 7 | IDYAIDEAYA BIOSCIENCES INC | 497,240 | $18.5M | 3.5% |
| 8 | ATRCATRICURE INC | 597,431 | $16.7M | 3.2% |
| 9 | XENEXENON PHARMACEUTICALS INC | 250,772 | $15.1M | 2.9% |
| 10 | CYTKCYTOKINETICS INC | 171,998 | $14.7M | 2.8% |
| 11 | RCUSARCUS BIOSCIENCES INC | 441,829 | $13.6M | 2.6% |
| 12 | ASCENDIS PHARMA A/S | 48,469 | $12.9M | 2.5% |
| 13 | NBIXNEUROCRINE BIOSCIENCES INC | 57,769 | $9.7M | 1.9% |
| 14 | AXGNAXOGEN INC | 208,960 | $9.7M | 1.8% |
| 15 | PODDINSULET CORP | 61,870 | $9.4M | 1.8% |
| 16 | EWTXEDGEWISE THERAPEUTICS INC | 226,819 | $9.2M | 1.8% |
| 17 | BCAXBICARA THERAPEUTICS INC | 284,955 | $8.5M | 1.6% |
| 18 | IBBISHARES NASDAQ BIOTECH INDX | 42,595 | $8.1M | 1.5% |
| 19 | SNDXSYNDAX PHARMACEUTICALS INC | 335,255 | $7.3M | 1.4% |
| 20 | MPLTMAPLIGHT THERAPEUTICS INC | 171,006 | $6.1M | 1.2% |
| 21 | LRMRLARIMAR THERAPEUTICS INC | 2.0M | $6.1M | 1.2% |
| 22 | IPSCCENTURY THERAPEUTICS INC | 2.4M | $5.9M | 1.1% |
| 23 | DXCMDEXCOM INC | 86,279 | $5.8M | 1.1% |
| 24 | IMVTIMMUNOVANT INC | 149,524 | $5.8M | 1.1% |
| 25 | INGNINOGEN INC | 845,179 | $5.5M | 1% |
| 26 | TNDMTANDEM DIABETES CARE INC | 355,208 | $5.4M | 1% |
| 27 | ALKERMES PLC | 101,266 | $5.3M | 1% |
| 28 | STOKSTOKE THERAPEUTICS INC | 130,875 | $4.3M | 0.8% |
| 29 | ALLOALLOGENE THERAPEUTICS INC | 2.0M | $4.2M | 0.8% |
| 30 | BCRXBIOCRYST PHARMACEUTICALS INC | 400,248 | $4.0M | 0.8% |
| 31 | LKFTLAKEFRONT BIOTHERAPEUTICS NV | 130,175 | $3.9M | 0.7% |
| 32 | KIDSORTHOPEDIATRICS CORP | 189,130 | $3.6M | 0.7% |
| 33 | HELPCYBIN INC | 514,061 | $3.4M | 0.6% |
| 34 | RAPPRAPPORT THERAPEUTICS INC | 75,000 | $3.1M | 0.6% |
| 35 | KYMRKYMERA THERAPEUTICS INC | 27,000 | $3.1M | 0.6% |
| 36 | PROQR THERAPEUTICS NV | 1.5M | $2.8M | 0.5% |
| 37 | NGNENEUROGENE INC | 89,032 | $2.8M | 0.5% |
| 38 | ANLADLAI NORTYE LTD | 239,553 | $2.8M | 0.5% |
| 39 | PRCTPROCEPT BIOROBOTICS CORP | 120,000 | $2.7M | 0.5% |
| 40 | AQSTAQUESTIVE THERAPEUTICS INC | 645,915 | $2.7M | 0.5% |
| 41 | CLDXCELLDEX THERAPEUTICS INC | 68,518 | $2.5M | 0.5% |
| 42 | GPCRSTRUCTURE THERAPEUTICS INC | 46,500 | $2.5M | 0.5% |
| 43 | ALGNALIGN TECHNOLOGY INC | 14,000 | $2.4M | 0.5% |
| 44 | VKTXVIKING THERAPEUTICS INC | 59,516 | $2.3M | 0.4% |
| 45 | NGENNERVGEN PHARMA CORP | 1.1M | $2.2M | 0.4% |
| 46 | BIOHAVEN LTD | 137,593 | $2.0M | 0.4% |
| 47 | MAZEMAZE THERAPEUTICS INC | 65,000 | $1.9M | 0.4% |
| 48 | ALECALECTOR INC | 908,351 | $1.8M | 0.3% |
| 49 | LXEOLEXEO THERAPEUTICS INC | 377,059 | $1.8M | 0.3% |
| 50 | PROFPROFOUND MEDICAL CORP | 260,360 | $1.7M | 0.3% |
| 51 | RNAATRIUM THERAPEUTICS INC | 128,000 | $1.7M | 0.3% |
| 52 | ANNXANNEXON INC | 297,812 | $1.7M | 0.3% |
| 53 | CTMXCYTOMX THERAPEUTICS INC | 438,407 | $1.6M | 0.3% |
| 54 | RAREULTRAGENYX PHARMACEUTICAL INC | 47,100 | $1.6M | 0.3% |
| 55 | EPRXEUPRAXIA PHARMACEUTICALS INC | 225,600 | $1.5M | 0.3% |
| 56 | DSGNDESIGN THERAPEUTICS INC | 102,600 | $1.5M | 0.3% |
| 57 | FATEFATE THERAPEUTICS INC | 525,000 | $1.4M | 0.3% |
| 58 | MEDIWOUND LTD | 94,405 | $1.4M | 0.3% |
| 59 | KURAKURA ONCOLOGY INC | 120,568 | $1.3M | 0.3% |
| 60 | SPRYARS PHARMACEUTICALS INC | 164,285 | $1.3M | 0.3% |
| 61 | MLYSMINERALYS THERAPEUTICS INC | 44,490 | $1.2M | 0.2% |
| 62 | IMMATICS NV | 116,960 | $1.2M | 0.2% |
| 63 | TELATELA BIO INC | 1.4M | $1.1M | 0.2% |
| 64 | POLYPID LTD | 207,900 | $1.1M | 0.2% |
| 65 | CRBPCORBUS PHARMACEUTICALS HLDGS | 107,773 | $1.0M | 0.2% |
| 66 | INSPINSPIRE MEDICAL SYSTEMS INC | 18,200 | $811,902 | 0.2% |
| 67 | ACETADICET BIO INC | 93,812 | $810,536 | 0.2% |
| 68 | SPTXSEAPORT THERAPEUTICS INC | 32,400 | $703,728 | 0.1% |
| 69 | MBXMBX BIOSCIENCES INC | 11,809 | $651,857 | 0.1% |
| 70 | BNTXBIONTECH SE | 7,000 | $651,350 | 0.1% |
| 71 | ARTVARTIVA BIOTHERAPEUTICS INC | 67,101 | $650,880 | 0.1% |
| 72 | PLRXPLIANT THERAPEUTICS INC | 487,000 | $555,180 | 0.1% |
| 73 | SCYXSCYNEXIS INC | 135,868 | $552,983 | 0.1% |
| 74 | EDITEDITAS MEDICINE INC | 170,470 | $552,323 | 0.1% |
| 75 | OBIOORCHESTRA BIOMED HOLDINGS INC | 126,841 | $547,319 | 0.1% |
| 76 | FHTXFOGHORN THERAPEUTICS INC | 111,859 | $545,872 | 0.1% |
| 77 | ARAYACCURAY INC | 1.7M | $433,235 | 0.1% |
| 78 | QTTBQ32 BIO INC | 32,896 | $419,095 | 0.1% |
| 79 | NVCTNUVECTIS PHARMA INC | 20,000 | $367,800 | 0.1% |
| 80 | COMPUGEN LTD | 168,232 | $360,016 | 0.1% |
| 81 | IBIOIBIO INC | 170,053 | $297,593 | 0.1% |
| 82 | AUTLAUTOLUS THERAPEUTICS LTD | 179,316 | $286,906 | 0.1% |
| 83 | BCYCBICYCLE THERAPEUTICS PLC | 64,492 | $273,446 | 0.1% |
| 84 | TNYATENAYA THERAPEUTICS INC | 300,000 | $221,730 | 0% |
| 85 | VRCAVERRICA PHARMACEUTICALS INC | 23,750 | $145,350 | 0% |
| 86 | ENGNENGENE THERAPEUTICS INC | 74,650 | $129,145 | 0% |
| 87 | KARDKARDIGAN INC | 5,000 | $119,250 | 0% |
| 88 | ADC THERAPEUTICS SA | 77,081 | $82,477 | 0% |
Source: SEC Form 13F-HR, reporting period 2026-06-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.